Search

Bharati R Dhruva

Examiner (ID: 3913)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
2
Issued Applications
1
Pending Applications
1
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7754539 [patent_doc_number] => 20120027726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Methods for Distributing High Levels of Therapeutic Agent Throughout the Cortex to Treat Neurological Disorders' [patent_app_type] => utility [patent_app_number] => 13/146640 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20270 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027726.pdf [firstpage_image] =>[orig_patent_app_number] => 13146640 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/146640
Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders Jan 28, 2010 Issued
Array ( [id] => 6431314 [patent_doc_number] => 20100143388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Antibody Composition-Producing Cell' [patent_app_type] => utility [patent_app_number] => 12/628083 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 77425 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143388.pdf [firstpage_image] =>[orig_patent_app_number] => 12628083 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/628083
Antibody Composition-Producing Cell Nov 29, 2009 Abandoned
Array ( [id] => 6314049 [patent_doc_number] => 20100111924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site' [patent_app_type] => utility [patent_app_number] => 12/607502 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8929 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111924.pdf [firstpage_image] =>[orig_patent_app_number] => 12607502 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/607502
Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site Oct 27, 2009 Abandoned
Array ( [id] => 7719887 [patent_doc_number] => 20120009222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'MODULATION OF THE IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/126260 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 32391 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009222.pdf [firstpage_image] =>[orig_patent_app_number] => 13126260 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/126260
MODULATION OF THE IMMUNE RESPONSE Oct 26, 2009 Abandoned
Array ( [id] => 7754718 [patent_doc_number] => 20120027807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'TISSUE ENGINEERED MYOCARDIUM AND METHODS OF PRODUCTION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/121279 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 63697 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027807.pdf [firstpage_image] =>[orig_patent_app_number] => 13121279 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/121279
TISSUE ENGINEERED MYOCARDIUM AND METHODS OF PRODUCTION AND USES THEREOF Oct 8, 2009 Abandoned
Array ( [id] => 6220668 [patent_doc_number] => 20100055763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'METHOD FOR THE PRODUCTION AND PURIFICATION OF RETROVIRAL VECTORS' [patent_app_type] => utility [patent_app_number] => 12/572943 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 32623 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055763.pdf [firstpage_image] =>[orig_patent_app_number] => 12572943 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/572943
METHOD FOR THE PRODUCTION AND PURIFICATION OF RETROVIRAL VECTORS Oct 1, 2009 Abandoned
Array ( [id] => 7680706 [patent_doc_number] => 20100105880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'PURIFICATION OF CARBON NANOTUBES VIA BIOMOLECULES' [patent_app_type] => utility [patent_app_number] => 12/571098 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3086 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105880.pdf [firstpage_image] =>[orig_patent_app_number] => 12571098 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/571098
PURIFICATION OF CARBON NANOTUBES VIA BIOMOLECULES Sep 29, 2009 Abandoned
Array ( [id] => 6230383 [patent_doc_number] => 20100184226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'MEDIA CONDITIONING FOR IMPROVING GENE DELIVERY EFFICIENCY TO DIFFERENTIATING EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/564903 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7571 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184226.pdf [firstpage_image] =>[orig_patent_app_number] => 12564903 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/564903
Media conditioning for improving gene delivery efficiency to differentiating embryonic stem cells Sep 21, 2009 Issued
Array ( [id] => 6302236 [patent_doc_number] => 20100068183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Methods of treating lysosomal storage related diseases by gene therapy' [patent_app_type] => utility [patent_app_number] => 12/586342 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26218 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068183.pdf [firstpage_image] =>[orig_patent_app_number] => 12586342 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/586342
Methods of treating lysosomal storage related diseases by gene therapy Sep 20, 2009 Abandoned
Array ( [id] => 6220073 [patent_doc_number] => 20100055168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'CATIONIC LIPIDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/557188 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 42761 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055168.pdf [firstpage_image] =>[orig_patent_app_number] => 12557188 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/557188
CATIONIC LIPIDS AND USES THEREOF Sep 9, 2009 Abandoned
Array ( [id] => 8538192 [patent_doc_number] => 08313913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa' [patent_app_type] => utility [patent_app_number] => 12/550160 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 41 [patent_no_of_words] => 71833 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12550160 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/550160
Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa Aug 27, 2009 Issued
Array ( [id] => 6486870 [patent_doc_number] => 20100093094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'TRIAZINE DENDRIMERS AND METHODS OF MAKING AND USING THE SAME FOR NUCLEIC ACID TRANSPORT' [patent_app_type] => utility [patent_app_number] => 12/549182 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 4673 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093094.pdf [firstpage_image] =>[orig_patent_app_number] => 12549182 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/549182
TRIAZINE DENDRIMERS AND METHODS OF MAKING AND USING THE SAME FOR NUCLEIC ACID TRANSPORT Aug 26, 2009 Abandoned
Array ( [id] => 6478177 [patent_doc_number] => 20100092395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'ACOUSTICALLY DELIVERING METHODS AND COMPOSITONS FOR REMOTE TREATMENT OF A TUMOR' [patent_app_type] => utility [patent_app_number] => 12/541965 [patent_app_country] => US [patent_app_date] => 2009-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6836 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092395.pdf [firstpage_image] =>[orig_patent_app_number] => 12541965 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/541965
ACOUSTICALLY DELIVERING METHODS AND COMPOSITONS FOR REMOTE TREATMENT OF A TUMOR Aug 15, 2009 Abandoned
Array ( [id] => 9951246 [patent_doc_number] => 09000033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Composition for improving skin condition and appearance' [patent_app_type] => utility [patent_app_number] => 12/512368 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 8409 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12512368 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/512368
Composition for improving skin condition and appearance Jul 29, 2009 Issued
Array ( [id] => 6094717 [patent_doc_number] => 20110219462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases' [patent_app_type] => utility [patent_app_number] => 13/054509 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22612 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20110219462.pdf [firstpage_image] =>[orig_patent_app_number] => 13054509 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/054509
G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases Jul 1, 2009 Abandoned
Array ( [id] => 6218381 [patent_doc_number] => 20110138488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'DEFICIENCY IN THE HISTONE DEMETHYLASE JHDM2A RESULTS IN IMPAIRED ENERGY EXPENDITURE AND OBESITY' [patent_app_type] => utility [patent_app_number] => 12/999059 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21365 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20110138488.pdf [firstpage_image] =>[orig_patent_app_number] => 12999059 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/999059
DEFICIENCY IN THE HISTONE DEMETHYLASE JHDM2A RESULTS IN IMPAIRED ENERGY EXPENDITURE AND OBESITY Jun 22, 2009 Abandoned
Array ( [id] => 5943620 [patent_doc_number] => 20110104240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections' [patent_app_type] => utility [patent_app_number] => 13/000555 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19266 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104240.pdf [firstpage_image] =>[orig_patent_app_number] => 13000555 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/000555
Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections Jun 22, 2009 Abandoned
Array ( [id] => 6167905 [patent_doc_number] => 20110162092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'COMPOSITION COMPRISED OF AKAP12 AND USES OF AKAP12 MUTANT ZEBRAFISH AS AN ANIMAL MODEL' [patent_app_type] => utility [patent_app_number] => 12/997653 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8723 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20110162092.pdf [firstpage_image] =>[orig_patent_app_number] => 12997653 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/997653
COMPOSITION COMPRISED OF AKAP12 AND USES OF AKAP12 MUTANT ZEBRAFISH AS AN ANIMAL MODEL Jun 11, 2009 Abandoned
Array ( [id] => 10176276 [patent_doc_number] => 09206471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Self-replicating materials' [patent_app_type] => utility [patent_app_number] => 12/482823 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 62 [patent_no_of_words] => 14760 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12482823 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/482823
Self-replicating materials Jun 10, 2009 Issued
Array ( [id] => 8363696 [patent_doc_number] => 08252761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Method of increasing murine ES cell differentiation with PCL2' [patent_app_type] => utility [patent_app_number] => 12/457407 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 9929 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12457407 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/457407
Method of increasing murine ES cell differentiation with PCL2 Jun 9, 2009 Issued
Menu